Strain SummaryCD-1
Strain Name |
CD-1 |
Strain Type(s) |
outbred |
Strain Synonym(s) |
CD1 • CD1 nontransgenic • CD-1 outbred • Charles River CD-1 • Crj:CD-1(ICR) • Crl: CD-1 (ICR) BR • Crl:CD-1 (ICR) BR • Crl:CD-1(ICR)BR • Crl:CD-1®(ICR) • ICR • ICR(CD-1) • ICR Crj:CD-1 • outbred CD1 • outbred CD-1 • random-bred Crl:CD-1(ICR)BR • (Swiss) CD-1 • Swiss CD-1 • Swiss CD-1® |
Description |
Outbred mice from Charles River. |
| Frequency | ||||||||
|---|---|---|---|---|---|---|---|---|
| Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
| Abdominal cavity tumor - histiocytic | Abdominal cavity |
10 - 12.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Adipose tissue lipoma | Kidney |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Adipose tissue lipoma | Abdominal cavity |
0.1 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Adipose tissue lipoma | Peritoneum - Mesentery | 3'-azido-3'-deoxythymidine (AZT) |
1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Adipose tissue liposarcoma | Subcutis |
0.8 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Adipose tissue liposarcoma | Abdominal cavity |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Adrenal gland - Cortex adenocarcinoma | Adrenal gland - Cortex |
0.3 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex |
0 - 3.0 |
0.1 - 1.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | sodium arsenite |
26 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | diethylstilbestrol (DES) |
9.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | tamoxifen (TAM) |
5.7 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | sodium arsenite ⋅ diethylstilbestrol (DES) |
24 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | sodium arsenite ⋅ tamoxifen (TAM) |
20 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
0 - 1.7 |
0 - 1.7 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: Lung |
||||
| Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla | 3'-azido-3'-deoxythymidine (AZT) |
2.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla | sodium barbital (BB) |
2.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Adrenal gland - Medulla pheochromocytoma - benign | Adrenal gland - Medulla |
0.3 - 1.1 |
0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Adrenal gland - Medulla pheochromocytoma - malignant | Adrenal gland - Medulla |
0 - 1.7 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: Lung |
||||
| Adrenal gland - Medulla pheochromocytoma - malignant | Adrenal gland - Medulla | muraglitazar |
0 |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Adrenal gland - Subcapsular cell adenoma | Adrenal gland - Subcapsular cell |
0 - 0.6 |
0 - 8.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Adrenal gland - Subcapsular cell adenoma | Adrenal gland - Subcapsular cell | muraglitazar |
0 - 1.7 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Adrenal gland - Subcapsular cell hyperplasia | Adrenal gland - Subcapsular cell |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Adrenal gland adenoma | Adrenal gland |
2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Adrenal gland tumor | Adrenal gland | 3'-azido-3'-deoxythymidine (AZT) |
0.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ampullary gland hyperplasia | Ampullary gland | diethylstilbestrol (DES) |
1.6 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Blood vessel hemangioma | Ovary | tamoxifen (TAM) |
0 - 18 |
References: Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Ovary |
0 - 3.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Blood vessel hemangioma | Ovary | diethylstilbestrol (DES) |
0 - 6.3 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Uterus | diethylstilbestrol (DES) |
2.9 - 8.3 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Blood vessel hemangioma | Testis | diethylstilbestrol (DES) |
1.6 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Blood vessel hemangioma | Liver |
0 - 4.5 |
1.5 - 5.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Spleen |
0.4 - 2.0 |
0.6 - 2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel hemangioma | Uterus |
0.9 - 3.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel hemangioma | Skin |
0.4 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangioma | Testis |
0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangioma | Lymph node - Mesenteric |
1.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangioma | Bone - Femur |
0.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangioma | Bone - Sternum |
0.8 |
0.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Blood vessel hemangioma | Tail |
1.3 |
1.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Blood vessel hemangioma | Leg |
14 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangioma | Stomach |
1.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangioma | (Unspecified organ) |
3.3 - 6.7 |
5.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Blood vessel hemangioma | Thymus |
1.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangioma | Abdominal cavity |
0.3 - 20 |
0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangioma | Ovary | sodium arsenite |
8.8 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Liver | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Liver | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Liver | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Ovary | sodium arsenite ⋅ diethylstilbestrol (DES) |
6.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Liver | sodium arsenite ⋅ diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Ovary | sodium arsenite ⋅ tamoxifen (TAM) |
5.7 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Liver | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangioma | Blood vessel |
1.7 - 3.3 |
0 - 0.8 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel hemangioma | Lymph node |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangioma | Lung |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangioma | Intestine - Small Intestine |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangioma | Epididymis |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Blood vessel hemangioma | Subcutis |
0.9 |
0.4 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangioma | Muscle |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangioma | Blood vessel | muraglitazar |
0 - 3.3 |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Blood vessel hemangiosarcoma | Liver |
0 - 0.4 |
0 - 5.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Liver | piperonyl butoxide (alpha-[2-(2-butoxyethoxy)ethoxy-4,5-methylenedioxy-2-propyltoluene) |
0 - 80 |
0 - 44 |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
|||
| Blood vessel hemangiosarcoma | Skin |
0.6 |
0.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Blood vessel hemangiosarcoma | Spleen |
0.7 |
0.4 - 5.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel hemangiosarcoma | (Unspecified organ) |
1.6 |
3.2 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Blood vessel hemangiosarcoma | Intestine - Large Intestine - Colon |
2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangiosarcoma | Bone |
5.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangiosarcoma | Muscle |
0 - 0.9 |
0.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangiosarcoma | Thoracic cavity |
12.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Blood vessel hemangiosarcoma | Uterus |
0 - 4.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Blood vessel hemangiosarcoma | Blood vessel |
0 - 3.3 |
0 - 6.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel hemangiosarcoma | Uterus | sodium arsenite |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Liver | sodium arsenite |
5.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Uterus | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Liver | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Uterus | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Liver | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Uterus | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Liver | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Uterus | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Liver | sodium arsenite ⋅ tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Blood vessel hemangiosarcoma | Lymph node |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangiosarcoma | Abdominal cavity |
0.1 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel hemangiosarcoma | Ovary |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Blood vessel hemangiosarcoma | Testis |
1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel hemangiosarcoma | Bone marrow |
1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel hemangiosarcoma | Subcutis |
20 - 50 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel hemangiosarcoma | Gallbladder |
2.5 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel hemangiosarcoma | Blood vessel | muraglitazar |
5.0 - 8.3 |
1.7 - 8.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Blood vessel hemangiosarcoma | Spleen | muraglitazar |
1.7 |
5.0 - 6.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Blood vessel hemangiosarcoma | Liver | muraglitazar |
3.3 |
6.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Blood vessel hemangiosarcoma | Subcutis | muraglitazar |
14 - 100 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel hemangiosarcoma | Uterus | 3'-azido-3'-deoxythymidine (AZT) |
4.2 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Blood vessel hemangiosarcoma | Blood vessel | 3'-azido-3'-deoxythymidine (AZT) |
observed |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Blood vessel hemangiosarcoma | Liver | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Blood vessel hemangiosarcoma | Spleen | N-methyl-N-nitrosourea (MNU) |
25.93 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Blood vessel hemangiosarcoma | Liver | N-methyl-N-nitrosourea (MNU) |
3.7 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Blood vessel hemangiosarcoma | Intestine | N-methyl-N-nitrosourea (MNU) |
14.81 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Blood vessel tumor | Subcutis |
0.8 |
0.3 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Blood vessel tumor | Blood vessel |
3.3 - 5.0 |
5.0 - 6.7 |
10.0 - 20.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Blood vessel tumor | Blood vessel | muraglitazar |
5.0 - 8.3 |
1.7 - 8.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Blood vessel tumor | Lung |
1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel tumor | Uterus |
1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel tumor | Spleen |
1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel tumor | Liver |
1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Blood vessel tumor | Liver | muraglitazar |
1.7 - 8.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel tumor | Ovary | muraglitazar |
1.7 - 3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel tumor | Uterus | muraglitazar |
3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel tumor | Spleen | muraglitazar |
1.7 - 3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel tumor | Bone marrow | muraglitazar |
1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel tumor | Subcutis | muraglitazar |
1.7 - 5.9 |
33 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Blood vessel tumor | Lung | muraglitazar |
1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Blood vessel tumor | Blood vessel | 3'-azido-3'-deoxythymidine (AZT) |
10.0 - 20.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Blood vessel tumor | Blood vessel | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
10.0 - 20.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Blood vessel tumor | Blood vessel | sodium barbital (BB) |
10.0 - 20.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Bone marrow hyperplasia | Bone marrow |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Bone osteoma | Bone - Femur |
0.3 |
0.3 - 0.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Bone osteoma | Bone |
0.2 - 17 |
0 - 33 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Bone osteoma | Bone - Rib |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
|||||
| Bone osteoma | Spleen |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Bone osteoma | Bone - Skull |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Bone osteosarcoma | Bone |
0 - 67 |
0 - 22 |
0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Lavigueur A, Mol Cell Biol 1989 Sep;9(9):3982-91 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
|||
| Bone osteosarcoma | Skin |
0.2 - 0.5 |
0.2 - 0.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Bone osteosarcoma | Stomach |
0.9 |
0.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Bone osteosarcoma | Uterus |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Bone osteosarcoma | Skin | sodium arsenite ⋅ tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Bone osteosarcoma | Bone - Rib |
0.3 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
|||||
| Bone osteosarcoma | Abdominal cavity |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Bone osteosarcoma | Subcutis |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Bone osteosarcoma | Subcutis | muraglitazar |
5.9 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Bone osteosarcoma | Stomach - Glandular | 3'-azido-3'-deoxythymidine (AZT) |
2.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Bone osteosarcoma | Subcutis | 3'-azido-3'-deoxythymidine (AZT) |
1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Bulbourethral gland adenoma | Bulbourethral gland |
2.0 |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
|||||
| CNS - Meninges meningioma - malignant | Bone - Skull |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Clitoral gland adenocarcinoma | Clitoral gland | diethylstilbestrol (DES) |
2.7 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Connective tissue - Fibroblast fibroma | Subcutis |
0.3 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Connective tissue - Fibroblast fibroma | Uterus |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Connective tissue - Fibroblast fibrosarcoma | Mammary gland | diethylstilbestrol (DES) |
observed |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Skin |
0 - 0.6 |
1.7 - 8.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Spleen |
0 |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Vagina |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
|||||
| Connective tissue - Fibroblast fibrosarcoma | Pancreas |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Subcutis |
0 - 75 |
0 - 50 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: not Lung , not Lymph node |
||||
| Connective tissue - Fibroblast fibrosarcoma | Ear - Outer ear |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Connective tissue - Fibroblast |
very low |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: not Lung , Lymph node - Mesenteric , Pancreas |
|||||
| Connective tissue - Fibroblast fibrosarcoma | Abdominal cavity |
0 |
0 - 50 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Connective tissue - Fibroblast fibrosarcoma | Subcutis | muraglitazar |
0 - 50 |
0 - 100 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: not Lung , not Lymph node - Mesenteric , not Pancreas , Lung , Lymph node |
|||
| Connective tissue - Fibroblast fibrosarcoma | Abdominal cavity | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Connective tissue - Fibroblast fibrosarcoma | Seminal vesicle | 3'-azido-3'-deoxythymidine (AZT) |
7.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ear - Zymbal gland carcinoma | Ear - Zymbal gland |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Ear - Zymbal gland carcinoma - sebaceous | Ear - Zymbal gland |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Eye - Harderian gland adenocarcinoma | Eye - Harderian gland |
0.1 - 2.4 |
0.1 - 0.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 Sites of Metastasis: Lung |
||||
| Eye - Harderian gland adenoma | Eye - Harderian gland |
1.5 - 11.8 |
1.9 - 19.4 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Eye - Harderian gland adenoma | Eye - Harderian gland | muraglitazar |
0 - 6.8 |
0 - 6.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Eye - Harderian gland carcinoma | Eye - Harderian gland |
0 - 3.3 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: Adipose tissue - Brown , Blood vessel - Aorta , Lung , Thymus |
||||
| Eye - Harderian gland carcinoma | Eye - Harderian gland | muraglitazar |
0 |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: not Adipose tissue - Brown , not Blood vessel - Aorta , not Lung , not Thymus |
|||
| Forestomach squamous cell carcinoma | Forestomach |
0 - 0.1 |
0 - 0.3 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Forestomach squamous cell carcinoma | Forestomach | muraglitazar |
0 - 1.7 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Forestomach squamous cell papilloma | Forestomach |
0 - 1.7 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Forestomach squamous cell papilloma | Forestomach | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Forestomach tumor | Forestomach |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||||
| Forestomach tumor | Forestomach | 3'-azido-3'-deoxythymidine (AZT) |
observed - 3.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Gallbladder adenoma | Gallbladder |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Gallbladder adenoma | Gallbladder | muraglitazar |
0 |
0 - 3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Gallbladder hyperplasia - focal | Gallbladder |
0 - observed |
0 - observed |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Gallbladder hyperplasia - focal | Gallbladder | muraglitazar |
0 - observed |
observed |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Gallbladder papilloma | Gallbladder |
0.1 - 1.1 |
0.1 - 1.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Genital tract tumor | Genital tract |
0 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
|||||
| Genital tract tumor | Genital tract | diethylstilbestrol (DES) |
4.8 - 35 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Genital tract tumor | Genital tract | 17beta-estradiol (E2) |
0 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Genital tract tumor | Genital tract | dimethylstilbestrol (DMS) |
0 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Head squamous cell carcinoma | Head | muraglitazar |
50 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Head squamous cell carcinoma | Head |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Head squamous cell papilloma | Head | muraglitazar |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Head squamous cell papilloma | Head |
100 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Intestine - Large Intestine - Anus adenoma | Intestine - Large Intestine - Anus |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Intestine - Large Intestine - Anus squamous cell carcinoma | Intestine - Large Intestine - Anus |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Intestine - Large Intestine - Cecum carcinoma | Intestine - Large Intestine - Cecum |
1.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Intestine - Large Intestine squamous cell carcinoma | Intestine - Large Intestine |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Intestine - Small Intestine - Duodenum adenoma | Intestine - Small Intestine - Duodenum |
0 - 0.4 |
0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Intestine - Small Intestine - Duodenum adenoma | Intestine - Small Intestine - Duodenum | muraglitazar |
0 - 1.7 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Intestine - Small Intestine - Duodenum hyperplasia - avillous | Intestine - Small Intestine - Duodenum |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Intestine - Small Intestine - Jejunum adenoma | Intestine - Small Intestine - Jejunum |
2.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Intestine - Small Intestine - Jejunum carcinoma | Intestine - Small Intestine - Jejunum |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Intestine - Small Intestine - Jejunum carcinoma | Intestine - Small Intestine - Jejunum | muraglitazar |
0 - 1.7 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Intestine - Small Intestine adenocarcinoma | Intestine - Small Intestine |
0.1 - 0.2 |
0 - 1.9 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Intestine - Small Intestine adenoma | Intestine - Small Intestine | sodium arsenite ⋅ tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Intestine - Small Intestine adenoma | Intestine - Small Intestine |
0.1 - 1.9 |
0.2 - 1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Intestine - Small Intestine adenoma | Intestine - Small Intestine | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Intestine adenocarcinoma | Intestine | N-methyl-N-nitrosourea (MNU) |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Intestine metaplasia | Intestine | N-methyl-N-nitrosourea (MNU) |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Intestine metaplasia | Intestine |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
|||||
| Intestine tumor | Intestine | AIN-76A |
0 |
0 |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Intestine tumor | Intestine | New western diet (NWD) TD.96096 ⋅ AIN-76A |
0 - 10 |
0 - 10 |
5 - 10 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Intestine tumor | Intestine | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
0 |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Kidney - Renal tubule adenoma | Kidney - Renal tubule |
0 |
0.4 - 0.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Kidney - Renal tubule carcinoma | Kidney - Renal tubule |
0 - 5.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Kidney - Renal tubule hyperplasia - cystic | Kidney - Renal tubule | sodium arsenite |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Kidney - Renal tubule hyperplasia - cystic | Kidney - Renal tubule | sodium arsenite ⋅ tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Kidney adenocarcinoma | Kidney |
0.1 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Kidney adenoma | Kidney |
0.1 |
0.3 - 1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Kidney adenoma - tubular | Kidney |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Kidney adenoma - tubular | Kidney | muraglitazar |
0 |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Kidney carcinoma | Kidney |
0 - 0.1 |
0.1 - 0.2 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 Sites of Metastasis: Lung |
||||
| Kidney carcinoma | Kidney | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Kidney carcinoma | Kidney | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Kidney carcinoma | Kidney | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Kidney carcinoma | Kidney | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Kidney carcinoma | Kidney | sodium arsenite ⋅ tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 Sites of Metastasis: Lung |
||||
| Kidney cyst | Kidney |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Kidney hyperplasia | Kidney |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Kidney hyperplasia | Kidney | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Kidney hyperplasia | Kidney | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Kidney hyperplasia | Kidney | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Leg squamous cell papilloma | Leg |
50 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell lymphoma | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell |
16.1 - 34.8 |
6.5 - 9.5 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell lymphoma | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell | 3'-azido-3'-deoxythymidine (AZT) |
0 - 21.4 |
0 - 7.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell lymphoma | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 - 30.4 |
0 - 4.3 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell lymphoma | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell | sodium barbital (BB) |
11.1 - 20 |
0 - 4.5 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell lymphoma - plasmacytic | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
0.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Lymphocyte - T-lymphocyte lymphoma - lymphoblastic | Leukocyte - Lymphocyte - T-lymphocyte |
4.3 - 12.9 |
3.2 - 4.8 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Leukocyte - Lymphocyte - T-lymphocyte lymphoma - lymphoblastic | Leukocyte - Lymphocyte - T-lymphocyte | 3'-azido-3'-deoxythymidine (AZT) |
0 - 25 |
0 - 7.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Lymphocyte - T-lymphocyte lymphoma - lymphoblastic | Leukocyte - Lymphocyte - T-lymphocyte | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
7.7 - 13.0 |
8.7 - 14.3 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Lymphocyte - T-lymphocyte lymphoma - lymphoblastic | Leukocyte - Lymphocyte - T-lymphocyte | sodium barbital (BB) |
5.6 - 25 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Lymphocyte - Thymocyte lymphoma | Thymus | 3'-azido-3'-deoxythymidine (AZT) |
0 - 7.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Leukocyte - Lymphocyte hyperplasia | Lymph node - Mandibular |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Lymphocyte hyperplasia | Lymph node - Mesenteric |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Lymphocyte hyperplasia | Spleen |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Lymphocyte hyperplasia | Thymus |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Lymphocyte leukemia - lymphocytic | Spleen |
4.2 - 5.1 |
3.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||||
| Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte | 3'-azido-3'-deoxythymidine (AZT) |
0 - 3.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte | sodium barbital (BB) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Leukocyte - Lymphocyte lymphoma - lymphocytic | Leukocyte - Lymphocyte |
observed |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Liver |
0.2 - 0.7 |
0 - 0.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
0 - 15 |
0 - 5.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Uterus |
0 - 12.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Skin |
0.4 |
0.4 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Epididymis |
2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Uterus - Cervix |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Connective tissue |
20 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Vagina |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Lymph node - Mesenteric |
2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte | muraglitazar |
3.3 - 10 |
0 - 3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Uterus | 3'-azido-3'-deoxythymidine (AZT) |
4.2 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte | 3'-azido-3'-deoxythymidine (AZT) |
0 - 11.1 |
0 - 4.3 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 - 4.3 |
0 - 4.3 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte | sodium barbital (BB) |
0 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Skin |
1.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Preputial gland (male) |
3.1 - 5.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Epididymis |
0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Ear |
12.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Clitoral gland |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Vagina |
1.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - malignant | Spleen |
0.1 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - malignant | Stomach |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - malignant | Liver |
0.3 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - malignant | Subcutis |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - malignant | Thoracic cavity |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - malignant | Uterus |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell leukemia | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell |
0 - 1.7 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell leukemia | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell mastocytoma | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell |
0 |
0.2 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell mastocytoma - malignant | Subcutis |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell tumor | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell |
0.8 - 1.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
0 - 4.3 |
0 - 4.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) | 3'-azido-3'-deoxythymidine (AZT) |
0 - 3.1 |
0 - 3.8 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) | sodium barbital (BB) |
0 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte leukemia | Leukocyte |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Leukocyte leukemia | Leukocyte | sodium arsenite ⋅ diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Leukocyte leukemia | Leukocyte | sodium arsenite ⋅ tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Leukocyte leukemia - unclassified | Leukocyte |
0.1 - 0.3 |
0.1 - 0.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte leukemia - undifferentiated | Leukocyte |
20 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Leukocyte lymphoma | Leukocyte |
0 - 30 |
0 - low |
observed |
1.5 |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Lavigueur A, Mol Cell Biol 1989 Sep;9(9):3982-91 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 ⋅ Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||
| Leukocyte lymphoma | Leukocyte | piperonyl butoxide (alpha-[2-(2-butoxyethoxy)ethoxy-4,5-methylenedioxy-2-propyltoluene) |
low |
low |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
|||
| Leukocyte lymphoma | Leukocyte | 1-methyl-1-nitrosourea (MNU) |
10 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
||||
| Leukocyte lymphoma | Leukocyte | sodium arsenite |
5.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Leukocyte lymphoma | Leukocyte | diethylstilbestrol (DES) |
9.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Leukocyte lymphoma | Leukocyte | tamoxifen (TAM) |
17 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Leukocyte lymphoma | Leukocyte | sodium arsenite ⋅ diethylstilbestrol (DES) |
12 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Leukocyte lymphoma | Leukocyte | sodium arsenite ⋅ tamoxifen (TAM) |
29 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Leukocyte lymphoma | Thymus |
1.2 |
0.6 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte lymphoma | Spleen |
0.9 |
0.4 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte lymphoma | Lymph node |
0.6 |
0.6 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte lymphoma | Intestine - Small Intestine |
0.2 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte lymphoma | Kidney |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Leukocyte lymphoma | Leukocyte | muraglitazar |
8.3 - 22 |
3.3 - 12 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Leukocyte lymphoma | Leukocyte | 3'-azido-3'-deoxythymidine (AZT) |
0 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte lymphoma | Leukocyte | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 - 4.3 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte lymphoma | Leukocyte | sodium barbital (BB) |
0 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte lymphoma | Spleen | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Leukocyte lymphoma | Lymph node - Mesenteric | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Leukocyte lymphoma | Leukocyte | New western diet (NWD) TD.96096 ⋅ AIN-76A |
55 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Leukocyte lymphoma | Lymph node - Mesenteric | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Leukocyte lymphoma | Spleen | N-methyl-N-nitrosourea (MNU) |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Leukocyte lymphoma | Thymus | N-methyl-N-nitrosourea (MNU) |
7.41 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Leukocyte lymphoma - immunoblastic | Leukocyte |
0 |
0 - 9.5 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Leukocyte lymphoma - immunoblastic | Leukocyte | 3'-azido-3'-deoxythymidine (AZT) |
0 - 6.25 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte lymphoma - immunoblastic | Leukocyte | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte lymphoma - immunoblastic | Leukocyte | sodium barbital (BB) |
0 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Leukocyte lymphoma - lymphoblastic | Leukocyte |
1.4 - 2.3 |
1.7 - 6.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Leukocyte lymphoma - lymphoblastic | Adipose tissue | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Leukocyte lymphoma - lymphocytic | Leukocyte |
1.7 - 9.8 |
3.3 - 6.4 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| Leukocyte lymphoma - mixed | Leukocyte |
1.8 |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| Leukocyte lymphoma - pleomorphic | Leukocyte |
15 - 23.3 |
7.9 - 9.6 |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |
|||
| Leukocyte lymphoma - unclassified | Leukocyte |
7.8 - 8.4 |
3.6 - 18.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Leukocyte neoplasm | Leukocyte |
observed - 16.4 |
observed - 6.8 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: (Unspecified organ) |
||||
| Leukocyte neoplasm | Leukocyte | muraglitazar |
observed |
observed - 10 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Liver - Bile duct cholangiocarcinoma | Liver - Bile duct |
0 - 0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver - Bile duct cholangiocarcinoma | Liver - Bile duct | sodium arsenite |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver - Bile duct cholangiocarcinoma | Liver - Bile duct | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver - Bile duct cholangiocarcinoma | Liver - Bile duct | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver - Bile duct cholangiocarcinoma | Liver - Bile duct | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver - Bile duct cholangiocarcinoma | Liver - Bile duct | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver - Bile duct cholangioma | Liver - Bile duct |
0.1 - 2.0 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
||||
| Liver - Bile duct cholangioma | Liver - Bile duct | piperonyl butoxide (alpha-[2-(2-butoxyethoxy)ethoxy-4,5-methylenedioxy-2-propyltoluene) |
0 - 1.6 |
0 |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
|||
| Liver - Hepatocyte foci | Liver - Hepatocyte | ZnSO4 |
0 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver - Hepatocyte foci | Liver - Hepatocyte | ZnSO4 ⋅ N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN) |
0 - observed |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver - Hepatocyte foci | Liver - Hepatocyte | ZnSO4 ⋅ phenobarbital (PB) ⋅ N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN) |
0 - observed |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver - Hepatocyte foci | Liver - Hepatocyte | ZnSO4 ⋅ phenobarbital (PB) |
0 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver - Hepatocyte hyperplasia | Liver - Hepatocyte |
0 |
2.0 |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
||||
| Liver - Hepatocyte hyperplasia | Liver - Hepatocyte | piperonyl butoxide (alpha-[2-(2-butoxyethoxy)ethoxy-4,5-methylenedioxy-2-propyltoluene) |
14 - 32 |
9.9 - 38 |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
|||
| Liver - Hepatocyte neoplasia | Liver - Hepatocyte | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Liver - Hepatocyte preneoplastic lesion | Liver - Hepatocyte | 1-methyl-1-nitrosourea (MNU) |
0 |
40 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver - Hepatocyte preneoplastic lesion | Liver - Hepatocyte | 1-methyl-1-nitrosourea (MNU) ⋅ hydroquinone (HQ) |
13 |
91 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver - Hepatocyte preneoplastic lesion | Liver - Hepatocyte | 1-methyl-1-nitrosourea (MNU) ⋅ 1,1-dimethylhydrazine (UDMH) |
0 |
40 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver - Hepatocyte preneoplastic lesion | Liver - Hepatocyte | hydroquinone (HQ) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver - Hepatocyte preneoplastic lesion | Liver - Hepatocyte | 1,1-dimethylhydrazine (UDMH) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver adenoma | Liver |
0 |
12.9 - 25 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Liver adenoma | Liver | 3'-azido-3'-deoxythymidine (AZT) |
0 - 20 |
15.8 - 66.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Liver carcinoma | Liver |
0 - 9.1 |
0 - 40 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 Sites of Metastasis: not Lung |
||||
| Liver carcinoma | Liver | 3'-azido-3'-deoxythymidine (AZT) |
0 - 10 |
4.2 - 37.5 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 Sites of Metastasis: Lung |
|||
| Liver carcinoma | Liver | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Liver carcinoma - histiocytic | Liver |
2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Liver hepatoblastoma | Liver |
0 |
0.4 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Liver hepatoblastoma | Liver | 3'-azido-3'-deoxythymidine (AZT) |
14.8 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Liver hepatocellular adenoma | Liver |
0 - 5.2 |
0 - 28.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 ⋅ Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular adenoma | Liver | piperonyl butoxide (alpha-[2-(2-butoxyethoxy)ethoxy-4,5-methylenedioxy-2-propyltoluene) |
0 - 16 |
0 - 26 |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
|||
| Liver hepatocellular adenoma | Liver | 1-methyl-1-nitrosourea (MNU) |
0 |
10 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular adenoma | Liver | 1-methyl-1-nitrosourea (MNU) ⋅ hydroquinone (HQ) |
0 |
45 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular adenoma | Liver | 1-methyl-1-nitrosourea (MNU) ⋅ 1,1-dimethylhydrazine (UDMH) |
0 |
13 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular adenoma | Liver | hydroquinone (HQ) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular adenoma | Liver | 1,1-dimethylhydrazine (UDMH) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular adenoma | Liver | ZnSO4 |
0 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver hepatocellular adenoma | Liver | ZnSO4 ⋅ N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN) |
0 - observed |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver hepatocellular adenoma | Liver | ZnSO4 ⋅ phenobarbital (PB) ⋅ N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN) |
0 - observed |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver hepatocellular adenoma | Liver | ZnSO4 ⋅ phenobarbital (PB) |
0 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver hepatocellular adenoma | Liver | sodium arsenite |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular adenoma | Liver | diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular adenoma | Liver | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular adenoma | Liver | sodium arsenite ⋅ diethylstilbestrol (DES) |
9.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular adenoma | Liver | sodium arsenite ⋅ tamoxifen (TAM) |
8.6 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular adenoma | Liver | muraglitazar |
0 - 3.3 |
0 - 5.0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Liver hepatocellular adenoma | Liver | New western diet (NWD) TD.96096 ⋅ AIN-76A |
0 |
0 - 10 |
0 - 5 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Liver hepatocellular adenoma | Liver | AIN-76A |
0 |
10 |
5 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Liver hepatocellular adenoma | Liver | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
0 |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Liver hepatocellular carcinoma | Liver |
0 - 8.6 |
0 - 12.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 Sites of Metastasis: not Lung , Lung |
||||
| Liver hepatocellular carcinoma | Liver | piperonyl butoxide (alpha-[2-(2-butoxyethoxy)ethoxy-4,5-methylenedioxy-2-propyltoluene) |
0 - 80 |
0 - 53 |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
|||
| Liver hepatocellular carcinoma | Liver | 1-methyl-1-nitrosourea (MNU) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular carcinoma | Liver | 1-methyl-1-nitrosourea (MNU) ⋅ hydroquinone (HQ) |
0 |
9.1 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular carcinoma | Liver | 1-methyl-1-nitrosourea (MNU) ⋅ 1,1-dimethylhydrazine (UDMH) |
0 |
6.7 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular carcinoma | Liver | hydroquinone (HQ) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular carcinoma | Liver | 1,1-dimethylhydrazine (UDMH) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Liver hepatocellular carcinoma | Liver | ZnSO4 |
0 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver hepatocellular carcinoma | Liver | ZnSO4 ⋅ N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN) |
0 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver hepatocellular carcinoma | Liver | ZnSO4 ⋅ phenobarbital (PB) ⋅ N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN) |
0 - 40 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver hepatocellular carcinoma | Liver | ZnSO4 ⋅ phenobarbital (PB) |
0 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver hepatocellular carcinoma | Liver | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular carcinoma | Liver | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular carcinoma | Liver | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular carcinoma | Liver | sodium arsenite ⋅ diethylstilbestrol (DES) |
6.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular carcinoma | Liver | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Liver hepatocellular carcinoma | Liver | muraglitazar |
0 |
1.7 - 6.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: not Lung , Lung |
|||
| Liver hepatocellular carcinoma | Liver | New western diet (NWD) TD.96096 ⋅ AIN-76A |
10 - 60 |
0 - 70 |
5 - 65 |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
|
| Liver hepatocellular carcinoma | Liver | AIN-76A |
0 |
0 |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Liver hepatocellular carcinoma | Liver | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
0 - 10 |
0 - 5 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Liver hepatocellular carcinoma | Liver | N-methyl-N-nitrosourea (MNU) |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Liver hepatocellular tumor | Liver |
2.5 |
16.7 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| Liver neoplasm | Liver | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Liver tumor | Liver |
0 - 9.1 |
0 - 60 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Jhappan C, Cell 1990 Jun 15;61(6):1137-46 |
||||
| Liver tumor | Liver | (see notes) |
0 |
4.8 |
References: Takagi H, Cancer Res 1992 Oct 1;52(19):5171-7 |
|||
| Liver tumor | Liver | ZnSO4 |
0 |
0 |
References: Takagi H, Cancer Res 1992 Oct 1;52(19):5171-7 ⋅ Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
|||
| Liver tumor | Liver | ZnSO4 ⋅ castration |
0 |
References: Takagi H, Cancer Res 1992 Oct 1;52(19):5171-7 |
||||
| Liver tumor | Liver | ZnSO4 ⋅ ovariectomy |
0 |
References: Takagi H, Cancer Res 1992 Oct 1;52(19):5171-7 |
||||
| Liver tumor | Liver | ZnSO4 ⋅ testosterone ⋅ ovariectomy |
0 |
References: Takagi H, Cancer Res 1992 Oct 1;52(19):5171-7 |
||||
| Liver tumor | Liver | ZnSO4 ⋅ N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN) |
observed |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver tumor | Liver | ZnSO4 ⋅ phenobarbital (PB) ⋅ N-diethylnitrosamine (N,N-diethylnitrosamine) (N-nitrosodiethylamine) (NDEA) (diethylnitrosamine) (DEN) |
observed |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver tumor | Liver | ZnSO4 ⋅ phenobarbital (PB) |
0 |
References: Tamano S, Carcinogenesis 1994 Sep;15(9):1791-8 |
||||
| Liver tumor | Liver | 3'-azido-3'-deoxythymidine (AZT) |
0 - 40 |
30.4 - 83.3 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Liver tumor | Liver | AIN-76A |
0 |
0 - 10 |
0 - 10 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Liver tumor | Liver | New western diet (NWD) TD.96096 ⋅ AIN-76A |
60 - 80 |
70 - 80 |
65 - 80 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Liver tumor | Liver | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
10 |
5 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lung - Alveolus hyperplasia | Lung - Alveolus | 1-methyl-1-nitrosourea (MNU) |
9.1 |
20 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung - Alveolus hyperplasia | Lung - Alveolus | 1-methyl-1-nitrosourea (MNU) ⋅ hydroquinone (HQ) |
13 |
9.1 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung - Alveolus hyperplasia | Lung - Alveolus | 1-methyl-1-nitrosourea (MNU) ⋅ 1,1-dimethylhydrazine (UDMH) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung - Alveolus hyperplasia | Lung - Alveolus | hydroquinone (HQ) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung - Alveolus hyperplasia | Lung - Alveolus | 1,1-dimethylhydrazine (UDMH) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung adenocarcinoma | Lung |
2.9 - 17.2 |
4.3 - 20.0 |
observed |
1.0 |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Lavigueur A, Mol Cell Biol 1989 Sep;9(9):3982-91 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||
| Lung adenocarcinoma | Lung | sodium arsenite |
15 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenocarcinoma | Lung | diethylstilbestrol (DES) |
observed - 6.1 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenocarcinoma | Lung | tamoxifen (TAM) |
11 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenocarcinoma | Lung | sodium arsenite ⋅ diethylstilbestrol (DES) |
21 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenocarcinoma | Lung | sodium arsenite ⋅ tamoxifen (TAM) |
14 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenocarcinoma | Lung | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed - 55 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Lung adenocarcinoma | Lung | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Lung adenocarcinoma | Lung | N-methyl-N-nitrosourea (MNU) |
44.44 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Lung adenocarcinoma - acinar | Lung | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Lung adenocarcinoma - papillary | Lung | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Lung adenocarcinoma - well-differentiated | Lung | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Lung adenoma | Lung |
0 - 18.2 |
0 - 40 |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 ⋅ Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||
| Lung adenoma | Lung | piperonyl butoxide (alpha-[2-(2-butoxyethoxy)ethoxy-4,5-methylenedioxy-2-propyltoluene) |
very low |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
||||
| Lung adenoma | Lung | 1-methyl-1-nitrosourea (MNU) |
27 |
80 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung adenoma | Lung | 1-methyl-1-nitrosourea (MNU) ⋅ hydroquinone (HQ) |
87 |
55 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung adenoma | Lung | 1-methyl-1-nitrosourea (MNU) ⋅ 1,1-dimethylhydrazine (UDMH) |
62.5 |
47 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung adenoma | Lung | hydroquinone (HQ) |
6.7 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung adenoma | Lung | 1,1-dimethylhydrazine (UDMH) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung adenoma | Lung | sodium arsenite |
21 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenoma | Lung | diethylstilbestrol (DES) |
9.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenoma | Lung | tamoxifen (TAM) |
5.7 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenoma | Lung | sodium arsenite ⋅ diethylstilbestrol (DES) |
6.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenoma | Lung | sodium arsenite ⋅ tamoxifen (TAM) |
8.6 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Lung adenoma | Lung | muraglitazar |
5.0 - 12 |
12 - 15 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Lung adenoma | Lung | 3'-azido-3'-deoxythymidine (AZT) |
4.8 - 52.6 |
5.0 - 50 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Lung adenoma | Lung | New western diet (NWD) TD.96096 ⋅ AIN-76A |
0 - 30 |
0 - 20 |
5 - 20 |
15 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
|
| Lung adenoma | Lung | AIN-76A |
10 |
0 |
5 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lung adenoma | Lung | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
10 |
0 |
5 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lung carcinoma | Lung | 1-methyl-1-nitrosourea (MNU) |
9.1 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung carcinoma | Lung | 1-methyl-1-nitrosourea (MNU) ⋅ hydroquinone (HQ) |
6.7 |
36 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung carcinoma | Lung | 1-methyl-1-nitrosourea (MNU) ⋅ 1,1-dimethylhydrazine (UDMH) |
6.3 |
20 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung carcinoma | Lung | hydroquinone (HQ) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung carcinoma | Lung | 1,1-dimethylhydrazine (UDMH) |
0 |
0 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
|||
| Lung carcinoma | Lung |
0 - 18.2 |
1.7 - 20 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: not Blood vessel - Aorta , not Lymph node , not Thoracic cavity , Blood vessel - Aorta , Lymph node , Thoracic cavity |
||||
| Lung carcinoma | Lung | muraglitazar |
1.7 - 10 |
5.0 - 13 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: not Blood vessel - Aorta , not Lymph node , not Thoracic cavity |
|||
| Lung carcinoma | Lung | 3'-azido-3'-deoxythymidine (AZT) |
9.5 - 40 |
4.3 - 40 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Lung carcinoma | Lung | New western diet (NWD) TD.96096 ⋅ AIN-76A |
40 - 80 |
50 - 60 |
50 - 65 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lung carcinoma | Lung | AIN-76A |
0 |
0 |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lung carcinoma | Lung | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
0 |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lung neoplasm | Lung | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Lung tumor | Lung |
0 - 36.4 |
observed - 60 |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Lung tumor | Lung | diethylstilbestrol (DES) |
21 - 38 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Lung tumor | Lung | muraglitazar |
6.7 - 22 |
18 - 27 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Lung tumor | Lung | 3'-azido-3'-deoxythymidine (AZT) |
14.3 - 73.7 |
13.0 - 87.5 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Lung tumor | Lung | AIN-76A |
0 - 10 |
0 |
0 - 10 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lung tumor | Lung | New western diet (NWD) TD.96096 ⋅ AIN-76A |
70 - 80 |
0 - 70 |
70 - 75 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lung tumor | Lung | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
10 |
5 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
|||
| Lymph node tumor | Lymph node | AIN-76A |
10 - 20 |
0 - 10 |
5 - 30 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lymph node tumor | Lymph node | New western diet (NWD) TD.96096 ⋅ AIN-76A |
60 - 80 |
30 - 50 |
50 - 65 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Lymph node tumor | Lymph node | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
30 |
10 |
20 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Mammary gland adenocarcinoma | Mammary gland |
0 - 6.3 |
0 - 0.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 Sites of Metastasis: Liver , Lung |
||||
| Mammary gland adenocarcinoma | Mammary gland | sodium arsenite |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Mammary gland adenocarcinoma | Mammary gland | diethylstilbestrol (DES) |
observed |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Mammary gland adenocarcinoma | Mammary gland | 3'-azido-3'-deoxythymidine (AZT) |
0 - 25 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Mammary gland adenocarcinoma | Mammary gland | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 - 13.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Mammary gland adenocarcinoma | Mammary gland | sodium barbital (BB) |
0 - 5.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Mammary gland adenocarcinoma | Mammary gland | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Mammary gland adenoma | Mammary gland |
0.3 - 1.2 |
0 - 0.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Mammary gland carcinoma | Mammary gland |
0 - 3.0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Mammary gland carcinoma | Mammary gland | muraglitazar |
0 - 6.8 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: Lung |
||||
| Mammary gland carcinoma | Mammary gland | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Mammary gland carcinosarcoma | Mammary gland |
0 - 1.1 |
4.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
||||
| Mammary gland neoplasia - epithelial | Mammary gland | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Mammary gland tumor | Mammary gland |
3.8 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
|||||
| Mammary gland tumor | Mammary gland | diethylstilbestrol (DES) |
5.5 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Mammary gland tumor | Mammary gland | 3'-azido-3'-deoxythymidine (AZT) |
0 - 16.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Mammary gland tumor | Mammary gland | AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Mammary gland tumor | Mammary gland | New western diet (NWD) TD.96096 ⋅ AIN-76A |
20 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Mammary gland tumor | Mammary gland | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Mesodermal cell/mesoblast myxosarcoma | Mesodermal cell/mesoblast | diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Mesodermal cell/mesoblast myxosarcoma | Subcutis |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Mesodermal cell/mesoblast myxosarcoma | Subcutis | muraglitazar |
0 - 50 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: not Blood vessel - Aorta , not Lung , not Ovary , not Pancreas , not Spleen , not Stomach - Glandular , not Thoracic cavity |
|||
| Mesodermal cell/mesoblast myxosarcoma | Abdominal cavity |
17 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: Blood vessel - Aorta , Lung , Ovary , Pancreas , Spleen , Stomach - Glandular , Thoracic cavity |
||||
| Mesodermal cell/mesoblast myxosarcoma | Abdominal cavity | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Mesodermal cell/mesoblast sarcoma | Uterus | diethylstilbestrol (DES) |
2.8 - 3.4 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Mesodermal cell/mesoblast sarcoma | Seminal vesicle | diethylstilbestrol (DES) |
3.4 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Mesodermal cell/mesoblast sarcoma | Skin |
0 - 6.7 |
1.9 - 2.2 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Mesodermal cell/mesoblast sarcoma | Uterus - Endometrium - Stroma |
1.0 - 1.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Mesodermal cell/mesoblast sarcoma | Abdominal cavity |
10.5 |
17 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Mesodermal cell/mesoblast sarcoma | Ear |
25 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Mesodermal cell/mesoblast sarcoma | Vagina |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Mesodermal cell/mesoblast sarcoma | Kidney |
0.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Mesodermal cell/mesoblast sarcoma | Thoracic cavity |
4.2 - 7.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Mesodermal cell/mesoblast sarcoma | Uterus |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Mesodermal cell/mesoblast sarcoma | Skin | diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Mesodermal cell/mesoblast sarcoma | Uterus - Endometrium |
0.2 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Mesodermal cell/mesoblast sarcoma | CNS - Meninges |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Mesodermal cell/mesoblast sarcoma | CNS - Meninges | muraglitazar |
0 - 1.7 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Mesodermal cell/mesoblast sarcoma | Skin | 3'-azido-3'-deoxythymidine (AZT) |
2.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Mesodermal cell/mesoblast sarcoma | Intestine - Small Intestine | 3'-azido-3'-deoxythymidine (AZT) |
1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Mesodermal cell/mesoblast sarcoma | Abdominal cavity | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
2.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Mesodermal cell/mesoblast sarcoma - stromal | Uterus - Cervix | diethylstilbestrol (DES) |
4.5 - 33 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 Sites of Metastasis: Liver , Ovary , Oviduct , Spleen , Uterus - Uterine horn |
||||
| Mesodermal cell/mesoblast sarcoma - stromal | Uterus | diethylstilbestrol (DES) |
4.5 - 9.1 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Mesodermal cell/mesoblast sarcoma - stromal | Uterus - Endometrium - Stroma |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Mesodermal cell/mesoblast sarcoma - stromal | Uterus - Cervix - Stroma |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Mesodermal cell/mesoblast sarcoma - stromal | Uterus - Endometrium - Stroma | muraglitazar |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Mesodermal cell/mesoblast sarcoma - stromal | Uterus - Cervix - Stroma | muraglitazar |
0 - 1.8 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Mesodermal cell/mesoblast sarcoma - unclassified | Intestine - Small Intestine |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Mesodermal cell/mesoblast sarcoma - unclassified | Intestine - Large Intestine |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Mesodermal cell/mesoblast sarcoma - unclassified | Subcutis |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Mesodermal cell/mesoblast sarcoma - undifferentiated | Epididymis |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
|||||
| Mesodermal cell/mesoblast sarcoma - undifferentiated | Adrenal gland |
0.3 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Mesothelium mesothelioma | Lung |
0.1 |
0 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| Mesothelium mesothelioma | Heart |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Mesothelium mesothelioma | Thoracic cavity |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Mesothelium mesothelioma | Thoracic cavity | muraglitazar |
0 - 12.5 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 Sites of Metastasis: Abdominal cavity , Adrenal gland - Cortex , Gallbladder , Liver , Muscle - Striated - Skeletal , Pancreas , Skin , Spleen , Stomach - Glandular , Vagina |
|||
| Mesothelium mesothelioma - malignant | Abdominal cavity |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Muscle - Smooth hyperplasia | Uterus | tamoxifen (TAM) |
observed |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Muscle - Smooth leiomyoma | Uterus | tamoxifen (TAM) |
0 - 14 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Muscle - Smooth leiomyoma | Uterus |
0 - 9.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Muscle - Smooth leiomyoma | Ovary | diethylstilbestrol (DES) |
4.2 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Muscle - Smooth leiomyoma | Uterus | diethylstilbestrol (DES) |
2.9 - 14 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Muscle - Smooth leiomyoma | Uterus - Cervix | diethylstilbestrol (DES) |
2.8 - 50 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Muscle - Smooth leiomyoma | Stomach |
2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Muscle - Smooth leiomyoma | Ovary |
0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Muscle - Smooth leiomyoma | Uterus - Cervix |
0 - 4.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Muscle - Smooth leiomyoma | Oviduct |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Muscle - Smooth leiomyoma | Uterus | muraglitazar |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Muscle - Smooth leiomyoma | Uterus - Cervix | muraglitazar |
0 - 3.6 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Muscle - Smooth leiomyoma | Urinary bladder |
1.7 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Muscle - Smooth leiomyoma | Urinary bladder | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Muscle - Smooth leiomyosarcoma | Uterus | tamoxifen (TAM) |
0 - 4.5 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus |
0 - 4.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Muscle - Smooth leiomyosarcoma | Esophagus |
2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Muscle - Smooth leiomyosarcoma | Uterus - Cervix |
0 - 0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Muscle - Smooth leiomyosarcoma | Uterus | sodium arsenite |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus - Cervix | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus - Cervix | diethylstilbestrol (DES) |
0 - 10 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus - Cervix | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus - Cervix | sodium arsenite ⋅ diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus - Cervix | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Smooth leiomyosarcoma | Urinary bladder |
0.75 |
0 |
References: Chandra M, Toxicol Pathol 1991;19(2):164-7 |
||||
| Muscle - Smooth leiomyosarcoma | Subcutis |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Muscle - Smooth leiomyosarcoma | Vagina |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Muscle - Smooth leiomyosarcoma | Uterus | muraglitazar |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Muscle - Smooth leiomyosarcoma | Vagina | 3'-azido-3'-deoxythymidine (AZT) |
4.5 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Muscle - Smooth leiomyosarcoma | Uterus | 3'-azido-3'-deoxythymidine (AZT) |
3.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Muscle - Smooth leiomyosarcoma | Intestine - Large Intestine - Colon | 3'-azido-3'-deoxythymidine (AZT) |
2.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Muscle - Striated - Skeletal rhabdomyosarcoma | Skin |
1.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Muscle - Striated - Skeletal rhabdomyosarcoma | Skin | tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Striated - Skeletal rhabdomyosarcoma | Skin | sodium arsenite ⋅ diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Muscle - Striated - Skeletal rhabdomyosarcoma | Subcutis |
0.1 |
0.4 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Muscle - Striated - Skeletal rhabdomyosarcoma | Abdominal cavity |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Myoepithelial cell myoepithelioma - malignant | Salivary gland | sodium arsenite ⋅ diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Nose - Nasal cavity adenoma | Nose - Nasal cavity | 1-methyl-1-nitrosourea (MNU) |
10 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
||||
| Nose - Nasal cavity adenoma | Nose - Nasal cavity | 1-methyl-1-nitrosourea (MNU) ⋅ 1,1-dimethylhydrazine (UDMH) |
6.7 |
References: Tamura T, Cancer Lett 1999 Aug 23;143(1):71-80 |
||||
| Nose - Nasal cavity squamous cell carcinoma | Nose - Nasal cavity |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Oral cavity papilloma | Oral cavity |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Oral cavity squamous cell papilloma | Oral cavity |
100 |
100 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell | tamoxifen (TAM) |
0 - 14 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell | diethylstilbestrol (DES) |
observed - 10 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
0.1 - 0.2 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell | 3'-azido-3'-deoxythymidine (AZT) |
3.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed - 40 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell | AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary - Granulosa cell tumor - benign | Ovary - Granulosa cell |
0.9 - 1.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Ovary - Granulosa cell tumor - malignant | Ovary - Granulosa cell |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Ovary - Hilus cell cyst - epithelial | Ovary - Hilus cell |
observed |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary - Hilus cell hyperplasia - ductal | Ovary - Hilus cell |
observed |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary - Hilus cell lesion - papillary | Ovary - Hilus cell |
observed |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary - Sertoli cell tumor | Ovary - Sertoli cell | 3'-azido-3'-deoxythymidine (AZT) |
4.2 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ovary - Sertoli cell tumor - benign | Ovary - Sertoli cell |
1.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Ovary - Sex cord stromal cell tumor - benign | Ovary - Sex cord stromal cell |
0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Ovary - Theca cell thecoma | Ovary - Theca cell | 3'-azido-3'-deoxythymidine (AZT) |
3.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ovary - Theca cell thecoma | Ovary - Theca cell | New western diet (NWD) TD.96096 ⋅ AIN-76A |
0 - 10 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary - Theca cell thecoma | Ovary - Theca cell | AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary - Theca cell thecoma | Ovary - Theca cell | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary - Theca cell tumor | Ovary - Theca cell |
0.3 - 0.4 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Ovary - Theca cell tumor | Ovary - Theca cell | sodium barbital (BB) |
5.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ovary - Theca cell tumor | Ovary - Theca cell | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary adenoma | Ovary |
0 - 3.4 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Ovary adenoma | Ovary | sodium arsenite |
12 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary adenoma | Ovary | diethylstilbestrol (DES) |
6.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary adenoma | Ovary | tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary adenoma | Ovary | sodium arsenite ⋅ diethylstilbestrol (DES) |
18 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary adenoma | Ovary | sodium arsenite ⋅ tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary adenoma | Ovary | muraglitazar |
1.7 - 6.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Ovary adenoma - cystic | Ovary | New western diet (NWD) TD.96096 ⋅ AIN-76A |
10 - 20 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary adenoma - cystic | Ovary | AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary adenoma - cystic | Ovary | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary adenoma - tubulostromal | Ovary |
0 - 1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Ovary adenoma - tubulostromal | Ovary | muraglitazar |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Ovary carcinoma | Ovary |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Ovary carcinoma | Ovary | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary carcinoma | Ovary | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary carcinoma | Ovary | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary carcinoma | Ovary | sodium arsenite ⋅ diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 Sites of Metastasis: Liver |
||||
| Ovary carcinoma | Ovary | sodium arsenite ⋅ tamoxifen (TAM) |
5.7 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Ovary cyst | Ovary | tamoxifen (TAM) |
0 - 86 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
||||
| Ovary cyst | Ovary |
0 - 70 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 ⋅ McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
|||||
| Ovary cyst | Ovary | diethylstilbestrol (DES) |
observed - 100 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Ovary cyst | Ovary | 17beta-estradiol (E2) |
58 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Ovary cyst | Ovary | dimethylstilbestrol (DMS) |
60 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Ovary cyst | Ovary | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
|||
| Ovary cyst - epithelial | Ovary |
observed |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary cystadenoma | Ovary | tamoxifen (TAM) |
5.3 - 8.3 |
References: Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
||||
| Ovary cystadenoma | Ovary |
0.7 - 13 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Ovary cystadenoma | Ovary | diethylstilbestrol (DES) |
2.9 - 18 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Ovary cystadenoma | Ovary | muraglitazar |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Ovary cystadenoma | Ovary | 3'-azido-3'-deoxythymidine (AZT) |
3.1 - 7.4 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ovary cystadenoma | Ovary | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary cystadenoma - papillary | Ovary |
0 - 0.7 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary cystadenoma - papillary | Ovary | diethylstilbestrol (DES) |
observed - 8.3 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Ovary hyperplasia - ductal | Ovary |
observed |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary hyperplasia - epithelial | Ovary |
5 - 37.5 |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary lesion - epithelial | Ovary |
observed - 97.5 |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary lesion - papillary | Ovary |
0 - 15 |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary lesion - papillary | Adipose tissue - Gonadal fat pad |
observed |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary lesion - proliferative | Ovary |
observed - 37.5 |
References: Long GG, Toxicol Pathol 2002 Sep-Oct;30(5):592-8 |
|||||
| Ovary luteoma | Ovary |
0 - 1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Ovary luteoma | Ovary | muraglitazar |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Ovary papilloma | Ovary |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Ovary tumor | Ovary |
0 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
|||||
| Ovary tumor | Ovary | diethylstilbestrol (DES) |
2.8 - 4.2 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Ovary tumor | Ovary | 3'-azido-3'-deoxythymidine (AZT) |
0 - 11.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ovary tumor | Ovary | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ovary tumor | Ovary | sodium barbital (BB) |
0 - 5.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Ovary tumor | Ovary | AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary tumor | Ovary | New western diet (NWD) TD.96096 ⋅ AIN-76A |
20 - 30 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary tumor | Ovary | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Ovary tumor - gonadal stromal | Ovary |
4.3 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
|||||
| Ovary tumor - gonadal stromal | Ovary | diethylstilbestrol (DES) |
observed |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Ovary tumor - granulosa-theca cell - benign | Ovary |
3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Ovary tumor - granulosa-theca cell - benign | Ovary | muraglitazar |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Ovary tumor - granulosa-theca cell - malignant | Ovary |
3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Ovary tumor - granulosa-theca cell - malignant | Ovary | muraglitazar |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Oviduct adenoma | Oviduct |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Oviduct adenoma | Oviduct | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct adenoma | Oviduct | diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct adenoma | Oviduct | tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct adenoma | Oviduct | sodium arsenite ⋅ diethylstilbestrol (DES) |
6.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct adenoma | Oviduct | sodium arsenite ⋅ tamoxifen (TAM) |
8.6 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct carcinoma | Oviduct |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Oviduct carcinoma | Oviduct | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct carcinoma | Oviduct | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct carcinoma | Oviduct | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct carcinoma | Oviduct | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct carcinoma | Oviduct | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct hyperplasia | Oviduct | tamoxifen (TAM) |
30 - 100 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct hyperplasia | Oviduct |
0 - 29 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Oviduct hyperplasia | Oviduct | diethylstilbestrol (DES) |
14 - 73 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct hyperplasia | Oviduct | sodium arsenite |
79 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct hyperplasia | Oviduct | sodium arsenite ⋅ diethylstilbestrol (DES) |
79 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct hyperplasia | Oviduct | sodium arsenite ⋅ tamoxifen (TAM) |
71 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Oviduct papilloma | Oviduct |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| PNS - Schwann cell neurofibrosarcoma | Skin |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| PNS - Schwann cell neurofibrosarcoma | Skin | muraglitazar |
0 |
0 - 8.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| PNS - Schwann cell neurofibrosarcoma | Leg | 3'-azido-3'-deoxythymidine (AZT) |
1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| PNS - Schwann cell schwannoma | Heart |
0 |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| PNS - Schwann cell schwannoma - malignant | Bone - Skull |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Pancreas - Acinar cell adenoma | Pancreas - Acinar cell |
0 |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Pancreas - Islet of Langerhans adenoma | Pancreas - Islet of Langerhans |
0.1 - 0.9 |
0 - 7.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Pancreas - Islet of Langerhans adenoma | Pancreas - Islet of Langerhans | 3'-azido-3'-deoxythymidine (AZT) |
1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Pancreas - Islet of Langerhans adenoma | Pancreas - Islet of Langerhans | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Pancreas tumor | Pancreas | 3'-azido-3'-deoxythymidine (AZT) |
0.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Pancreas tumor | Pancreas | AIN-76A |
0 |
0 |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Pancreas tumor | Pancreas | New western diet (NWD) TD.96096 ⋅ AIN-76A |
0 - 10 |
0 - 10 |
0 - 5 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Pancreas tumor | Pancreas | New western diet (NWD) TD.96096 ⋅ L. reuteri ATCC-PTA-6475 ⋅ AIN-76A |
0 |
0 |
0 |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||
| Parathyroid gland adenoma | Parathyroid gland |
0 - 0.6 |
0 - 0.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Parathyroid gland adenoma | Parathyroid gland | muraglitazar |
0 |
0 - 2.4 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Pituitary gland - Anterior adenocarcinoma | Pituitary gland - Anterior |
0.2 |
0.2 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Pituitary gland - Anterior adenoma | Pituitary gland - Anterior |
1.1 - 4.7 |
0 - 0.2 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Pituitary gland adenoma | Pituitary gland |
0 - 6.8 |
0 - 3.4 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Pituitary gland adenoma | Pituitary gland | muraglitazar |
0 - 5.1 |
0 - 1.8 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Pituitary gland adenoma | Pituitary gland | 3'-azido-3'-deoxythymidine (AZT) |
2.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Pituitary gland adenoma | Pituitary gland | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
2.8 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Pituitary gland carcinoma | Pituitary gland |
1.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Placenta - Decidua deciduoma | Placenta - Decidua | tamoxifen (TAM) |
0 - 20 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Placenta - Decidua deciduoma | Placenta - Decidua |
0 - 3.1 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
|||||
| Placenta - Decidua deciduoma | Placenta - Decidua | diethylstilbestrol (DES) |
2.7 - 6.9 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Preputial gland (male) adenoma | Preputial gland (male) |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Prostate gland - Anterior lobe adenoma | Prostate gland - Anterior lobe |
0.3 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Prostate gland - Anterior lobe hyperplasia | Prostate gland - Anterior lobe | diethylstilbestrol (DES) |
3.4 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Prostate gland adenoma | Prostate gland |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Prostate gland hyperplasia | Prostate gland |
2.9 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
|||||
| Prostate gland hyperplasia | Prostate gland | diethylstilbestrol (DES) |
3.4 - 9.0 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Prostate gland tumor | Prostate gland | diethylstilbestrol (DES) |
3.4 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Reproductive system (sex not specified) tumor | Reproductive system (sex not specified) |
3 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||||
| Reproductive system (sex not specified) tumor | Reproductive system (sex not specified) | 3'-azido-3'-deoxythymidine (AZT) |
7 - 12 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Reproductive system (sex not specified) tumor - malignant | Reproductive system (sex not specified) | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Salivary gland - Parotid adenoma | Salivary gland - Parotid |
0.2 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Salivary gland - Submandibular adenoma | Salivary gland - Submandibular |
0 |
0.2 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Salivary gland adenocarcinoma | Salivary gland |
1.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Salivary gland carcinoma | Salivary gland |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Seminal vesicle adenocarcinoma | Seminal vesicle |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Seminal vesicle adenoma | Seminal vesicle |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Seminal vesicle adenoma | Seminal vesicle | 3'-azido-3'-deoxythymidine (AZT) |
3.6 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Seminal vesicle carcinosarcoma | Seminal vesicle | diethylstilbestrol (DES) |
2.0 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Seminal vesicle hyperplasia | Seminal vesicle | diethylstilbestrol (DES) |
2.0 - 3.4 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Seminal vesicle papilloma | Seminal vesicle | diethylstilbestrol (DES) |
1.0 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Seminal vesicle tumor | Seminal vesicle |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||||
| Seminal vesicle tumor | Seminal vesicle | 3'-azido-3'-deoxythymidine (AZT) |
0 - 10.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Seminal vesicle tumor | Seminal vesicle | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Seminal vesicle tumor | Seminal vesicle | sodium barbital (BB) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Skin - Epidermis - Basal cell carcinoma | Skin - Epidermis - Basal cell |
0.1 |
0 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Skin - Epidermis - Basal cell tumor | Skin - Epidermis - Basal cell |
0 - 1.9 |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Skin - Epidermis - Basal cell tumor - malignant | Skin - Epidermis - Basal cell |
0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Skin - Hair follicle - Basal cell trichoepithelioma | Skin - Hair follicle - Basal cell |
0 - 2.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
|||||
| Skin - Hair follicle tumor | Skin - Hair follicle |
0.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Skin - Melanocyte melanoma - benign | Skin - Melanocyte |
1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Skin adenoma - sebaceous | Skin |
0.9 |
1.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Skin adenoma - sebaceous | Skin | 3'-azido-3'-deoxythymidine (AZT) |
1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Skin keratoacanthoma | Skin |
0.1 - 2.0 |
0.1 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Skin keratoacanthoma | Skin | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
2.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Skin papilloma | Skin |
0 |
0.2 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Skin papilloma | Skin | 3'-azido-3'-deoxythymidine (AZT) |
2.0 |
2.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| Skin squamous cell carcinoma | Skin |
0.3 - 0.7 |
0.2 - 0.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Skin squamous cell papilloma | Skin |
0 - 20 |
0 - 0.2 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Skin squamous cell papilloma | Skin | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Stomach - Glandular - Pylorus hyperplasia | Stomach - Glandular - Pylorus | N-methyl-N-nitrosourea (MNU) |
observed |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular - Pylorus hyperplasia | Stomach - Glandular - Pylorus |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
|||||
| Stomach - Glandular - Pylorus lesion | Stomach - Glandular - Pylorus | N-methyl-N-nitrosourea (MNU) |
100 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular - Pylorus lesion | Stomach - Glandular - Pylorus |
100 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
|||||
| Stomach - Glandular - Pylorus preneoplastic lesion | Stomach - Glandular - Pylorus | N-methyl-N-nitrosourea (MNU) |
observed |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular - Pylorus preneoplastic lesion | Stomach - Glandular - Pylorus |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
|||||
| Stomach - Glandular - Pylorus tumor | Stomach - Glandular - Pylorus | N-methyl-N-nitrosourea (MNU) |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular - Pylorus tumor | Stomach - Glandular - Pylorus |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
|||||
| Stomach - Glandular adenocarcinoma | Stomach - Glandular |
0.3 |
0 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular adenocarcinoma | Stomach - Glandular | N-methyl-N-nitrosourea (MNU) |
18.52 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular adenocarcinoma - poorly differentiated | Stomach - Glandular | N-methyl-N-nitrosourea (MNU) |
observed |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular adenocarcinoma - signet ring cell | Stomach - Glandular | N-methyl-N-nitrosourea (MNU) |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular adenocarcinoma - well-differentiated | Stomach - Glandular | N-methyl-N-nitrosourea (MNU) |
observed |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular adenoma | Stomach - Glandular |
0 - 0.4 |
0 - 0.4 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular adenoma | Stomach - Glandular | N-methyl-N-nitrosourea (MNU) |
48.15 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular carcinoma | Stomach - Glandular |
0 |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Stomach - Glandular carcinoma | Stomach - Glandular | muraglitazar |
0 |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Stomach - Glandular papilloma | Stomach - Glandular |
0 |
0.3 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| Stomach - Glandular tumor | Stomach - Glandular | N-methyl-N-nitrosourea (MNU) |
observed |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach - Glandular tumor | Stomach - Glandular |
0 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
|||||
| Stomach adenocarcinoma | Stomach | N-methyl-N-nitrosourea (MNU) |
17.86 |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Stomach adenoma | Stomach |
1.0 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Stomach squamous cell papilloma | Stomach |
0.3 - 0.6 |
0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| Stomach tumor | Stomach | N-methyl-N-nitrosourea (MNU) |
observed |
References: Yamamoto M, Cancer Lett 2002 May 28;179(2):121-32 |
||||
| Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) | diethylstilbestrol (DES) |
1.5 - 6.9 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) |
0 - 2.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
|||||
| Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) | diethylstilbestrol (DES) |
1.5 - 3.2 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) | 3'-azido-3'-deoxythymidine (AZT) |
0 - 15.4 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) | sodium barbital (BB) |
0 - 9.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Testis - Leydig cell (Interstitial cell) tumor - benign | Testis - Leydig cell (Interstitial cell) |
0 - 1.9 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Testis - Leydig cell (Interstitial cell) tumor - benign | Testis - Leydig cell (Interstitial cell) | muraglitazar |
0 - 3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Testis - Leydig cell (Interstitial cell) tumor - malignant | Testis - Leydig cell (Interstitial cell) |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 Sites of Metastasis: Lung |
|||||
| Testis - Rete testis adenoma | Testis - Rete testis |
0 - 1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Testis - Rete testis adenoma | Testis - Rete testis | muraglitazar |
0 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Testis - Rete testis hyperplasia | Testis - Rete testis |
5.7 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
|||||
| Testis - Rete testis hyperplasia | Testis - Rete testis | diethylstilbestrol (DES) |
7.7 - 35 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Testis - Rete testis hyperplasia - lipoid | Testis - Rete testis | diethylstilbestrol (DES) |
1.9 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Testis - Rete testis tumor | Testis - Rete testis | diethylstilbestrol (DES) |
1.2 - 1.9 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Testis - Seminiferous tubules hyperplasia | Testis - Seminiferous tubules | diethylstilbestrol (DES) |
1.4 |
References: Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
||||
| Testis - Stroma tumor | Testis - Stroma |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Testis adenoma - papillary | Testis |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Thymus cyst | Thymus |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Thymus thymoma | Thymus |
0 - 0.7 |
0.1 |
1.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Lavigueur A, Mol Cell Biol 1989 Sep;9(9):3982-91 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||
| Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
0 - 1.7 |
0 - 3.3 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell | muraglitazar |
0 - 1.7 |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||
| Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
5.6 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell | sodium barbital (BB) |
5.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Thyroid gland - Follicular cell cyst | Thyroid gland - Follicular cell |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Thyroid gland - Medulla - C cell adenoma | Thyroid gland - Medulla - C cell | 3'-azido-3'-deoxythymidine (AZT) |
1.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Thyroid gland adenocarcinoma | Thyroid gland | sodium arsenite ⋅ diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Thyroid gland adenoma | Thyroid gland |
0.7 |
0.9 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| Thyroid gland tumor | Thyroid gland | 3'-azido-3'-deoxythymidine (AZT) |
0.9 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Tongue squamous cell papilloma | Tongue |
0.8 - 1.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Tooth ameloblastoma | Tooth |
100 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Tooth tumor - benign | Oral cavity |
100 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Urinary bladder - Transitional cell carcinoma - undifferentiated | Urinary bladder - Transitional cell | sodium arsenite ⋅ diethylstilbestrol (DES) |
observed |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder |
0 - 0.3 |
0 - 0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder | sodium arsenite ⋅ diethylstilbestrol (DES) |
9.1 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell carcinoma | Urinary bladder | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell hyperplasia | Urinary bladder |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Urinary bladder transitional cell hyperplasia | Urinary bladder | sodium arsenite |
15 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell hyperplasia | Urinary bladder | diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell hyperplasia | Urinary bladder | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell hyperplasia | Urinary bladder | sodium arsenite ⋅ diethylstilbestrol (DES) |
30 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell hyperplasia | Urinary bladder | sodium arsenite ⋅ tamoxifen (TAM) |
26 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell papilloma | Urinary bladder |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Urinary bladder transitional cell papilloma | Urinary bladder | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell papilloma | Urinary bladder | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell papilloma | Urinary bladder | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell papilloma | Urinary bladder | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder transitional cell papilloma | Urinary bladder | sodium arsenite ⋅ tamoxifen (TAM) |
2.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Urinary bladder tumor | Urinary bladder |
2.0 |
References: Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 |
|||||
| Uterus - Cervix - Stroma polyp | Uterus - Cervix - Stroma |
0 - 1.7 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Uterus - Cervix - Stroma polyp | Uterus - Cervix - Stroma | muraglitazar |
0 - 3.6 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Uterus - Cervix adenoma | Uterus - Cervix |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Uterus - Cervix adenoma | Uterus - Cervix | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix adenoma | Uterus - Cervix | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix adenoma | Uterus - Cervix | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix adenoma | Uterus - Cervix | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix adenoma | Uterus - Cervix | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix atypia | Uterus - Cervix | diethylstilbestrol (DES) |
2.9 - 8.3 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Cervix carcinoma | Uterus - Cervix | diethylstilbestrol (DES) |
4.2 - 18 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix carcinoma | Uterus - Cervix |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Uterus - Cervix carcinoma | Uterus - Cervix | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix carcinoma | Uterus - Cervix | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix carcinoma | Uterus - Cervix | sodium arsenite ⋅ diethylstilbestrol (DES) |
24 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix carcinoma | Uterus - Cervix | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix carcinoma | Uterus - Cervix | muraglitazar |
0 - 1.8 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Uterus - Cervix cyst - keratinized | Uterus - Cervix | diethylstilbestrol (DES) |
4.5 - 9.1 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Cervix hyperplasia - stromal | Uterus - Cervix | diethylstilbestrol (DES) |
2.9 - 8.3 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Cervix metaplasia - squamous | Uterus - Cervix |
1.2 - 4.2 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
|||||
| Uterus - Cervix metaplasia - squamous | Uterus - Cervix | diethylstilbestrol (DES) |
observed - 33 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Cervix papilloma | Uterus - Cervix | diethylstilbestrol (DES) |
5.3 - 25 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Cervix squamous cell carcinoma | Uterus - Cervix | sodium arsenite ⋅ diethylstilbestrol (DES) |
observed |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus - Cervix tumor | Uterus - Cervix | tamoxifen (TAM) |
0 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Uterus - Cervix tumor | Uterus - Cervix |
0 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
|||||
| Uterus - Cervix tumor | Uterus - Cervix | diethylstilbestrol (DES) |
0 - 50 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Cervix tumor | Uterus - Cervix | 3'-azido-3'-deoxythymidine (AZT) |
0 - 7.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Uterus - Endometrium - Stroma polyp | Uterus - Endometrium - Stroma |
0 - 17.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
|||||
| Uterus - Endometrium - Stroma polyp | Uterus - Endometrium - Stroma | muraglitazar |
0 - 6.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Uterus - Endometrium adenocarcinoma | Uterus - Endometrium |
0 |
References: Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
|||||
| Uterus - Endometrium adenocarcinoma | Uterus - Endometrium | tamoxifen (TAM) |
0 - 50 |
References: Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
||||
| Uterus - Endometrium carcinoma | Uterus - Endometrium | tamoxifen (TAM) |
0 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Uterus - Endometrium carcinoma | Uterus - Endometrium |
0 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
|||||
| Uterus - Endometrium hyperplasia | Uterus - Endometrium | diethylstilbestrol (DES) |
2.7 - 6.7 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Uterus - Endometrium hyperplasia | Uterus - Endometrium |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Uterus - Endometrium hyperplasia | Uterus - Endometrium | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| Uterus - Endometrium hyperplasia - atypical | Uterus - Endometrium |
0 |
References: Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
|||||
| Uterus - Endometrium hyperplasia - atypical | Uterus - Endometrium | tamoxifen (TAM) |
14 - 25 |
References: Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
||||
| Uterus - Endometrium hyperplasia - atypical | Uterus - Endometrium | diethylstilbestrol (DES) |
observed |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Endometrium hyperplasia - cystic | Uterus - Endometrium | diethylstilbestrol (DES) |
observed - 100 |
References: Li S, Cancer Res 1997 Oct 1;57(19):4356-9 ⋅ McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Uterus - Endometrium hyperplasia - cystic | Uterus - Endometrium |
0 - 83 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
|||||
| Uterus - Endometrium hyperplasia - cystic | Uterus - Endometrium | tamoxifen (TAM) |
21 - 38 |
References: Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
||||
| Uterus - Endometrium hyperplasia - cystic | Uterus - Endometrium | 17beta-estradiol (E2) |
0 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Endometrium hyperplasia - cystic | Uterus - Endometrium | dimethylstilbestrol (DMS) |
10 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus - Endometrium polyp | Uterus - Endometrium |
4.3 - 17 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
|||||
| Uterus - Endometrium polyp | Uterus - Endometrium | diethylstilbestrol (DES) |
8.6 - 31 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Uterus adenocarcinoma | Uterus |
0 - 0.4 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
|||||
| Uterus adenocarcinoma | Uterus | diethylstilbestrol (DES) |
0 - 16 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 Sites of Metastasis: Lymph node |
||||
| Uterus adenocarcinoma | Uterus | sodium arsenite ⋅ diethylstilbestrol (DES) |
observed |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus adenoma | Uterus |
0 - 0.6 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Maita K, Toxicol Pathol 1988;16(3):340-9 ⋅ Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Uterus adenoma | Uterus | sodium arsenite |
8.8 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus adenoma | Uterus | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus adenoma | Uterus | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus adenoma | Uterus | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus adenoma | Uterus | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus adenoma | Uterus | muraglitazar |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Uterus carcinoma | Uterus |
0 - 1.7 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 ⋅ Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Uterus carcinoma | Uterus | sodium arsenite |
5.9 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus carcinoma | Uterus | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus carcinoma | Uterus | tamoxifen (TAM) |
5.7 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus carcinoma | Uterus | sodium arsenite ⋅ diethylstilbestrol (DES) |
21 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus carcinoma | Uterus | sodium arsenite ⋅ tamoxifen (TAM) |
5.7 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Uterus carcinoma | Uterus | muraglitazar |
0 - 3.3 |
References: Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |
||||
| Uterus dysplasia | Uterus | tamoxifen (TAM) |
observed |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Uterus hyperplasia | Uterus | tamoxifen (TAM) |
0 - 100 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Uterus hyperplasia | Uterus |
0 - 75 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
|||||
| Uterus hyperplasia - atypical | Uterus | diethylstilbestrol (DES) |
2.9 - 17 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Uterus hyperplasia - atypical - focal | Uterus |
4.3 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
|||||
| Uterus metaplasia - papillary | Uterus | diethylstilbestrol (DES) |
2.9 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Uterus metaplasia - squamous | Uterus | tamoxifen (TAM) |
0 - 57 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
||||
| Uterus metaplasia - squamous | Uterus |
0 - observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
|||||
| Uterus metaplasia - squamous | Uterus | diethylstilbestrol (DES) |
observed - 30 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Uterus metaplasia - squamous | Uterus | 17beta-estradiol (E2) |
0 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus metaplasia - squamous | Uterus | dimethylstilbestrol (DMS) |
20 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus papilloma | Uterus |
0.6 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| Uterus polyp | Uterus | tamoxifen (TAM) |
observed |
References: Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
||||
| Uterus polyp | Uterus | 3'-azido-3'-deoxythymidine (AZT) |
3.1 - 9.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Uterus polyp - adenomatous | Uterus | tamoxifen (TAM) |
0 - 30 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| Uterus polyp - adenomatous | Uterus |
0 - 4.2 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
|||||
| Uterus squamous cell carcinoma | Uterus |
0.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
|||||
| Uterus tumor | Uterus |
0 - 13.0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
|||||
| Uterus tumor | Uterus | diethylstilbestrol (DES) |
0 - 14 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Uterus tumor | Uterus | 3'-azido-3'-deoxythymidine (AZT) |
0 - 21.4 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Uterus tumor | Uterus | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Uterus tumor | Uterus | sodium barbital (BB) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Uterus tumor - granular cell - benign | Uterus |
0.8 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Vagina - Basal cell hyperplasia | Vagina - Basal cell | diethylstilbestrol (DES) |
2.9 - 8.3 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Vagina adenocarcinoma | Vagina | diethylstilbestrol (DES) |
2.7 - 8.3 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Vagina adenoma | Vagina |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Vagina adenoma | Vagina | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina adenoma | Vagina | diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina adenoma | Vagina | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina adenoma | Vagina | sodium arsenite ⋅ diethylstilbestrol (DES) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina adenoma | Vagina | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina carcinoma | Vagina |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
|||||
| Vagina carcinoma | Vagina | sodium arsenite |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina carcinoma | Vagina | diethylstilbestrol (DES) |
3.0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina carcinoma | Vagina | tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina carcinoma | Vagina | sodium arsenite ⋅ diethylstilbestrol (DES) |
15 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina carcinoma | Vagina | sodium arsenite ⋅ tamoxifen (TAM) |
0 |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina carcinoma in situ | Vagina | diethylstilbestrol (DES) |
2.7 - 2.8 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Vagina papilloma | Vagina | diethylstilbestrol (DES) |
2.9 |
References: Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
||||
| Vagina squamous cell carcinoma | Vagina | sodium arsenite ⋅ diethylstilbestrol (DES) |
observed |
References: Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
||||
| Vagina squamous cell hyperplasia | Vagina |
observed |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
|||||
| Vagina tumor | Vagina | tamoxifen (TAM) |
0 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
||||
| Vagina tumor | Vagina |
0 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 ⋅ McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 ⋅ Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 ⋅ Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
|||||
| Vagina tumor | Vagina | diethylstilbestrol (DES) |
0 - 25 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Vagina tumor - epidermoid | Vagina | diethylstilbestrol (DES) |
observed - 25 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| Vagina tumor - epithelial | Vagina |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||||
| Vagina tumor - epithelial | Vagina | 3'-azido-3'-deoxythymidine (AZT) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Vagina tumor - epithelial | Vagina | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| Vagina tumor - epithelial | Vagina | sodium barbital (BB) |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| (Unspecified organ) histiocytoma - fibrous - malignant | Skin |
3.2 - 10.9 |
0 - 1.5 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| (Unspecified organ) histiocytoma - fibrous - malignant | Epididymis |
0.1 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
|||||
| (Unspecified organ) histiocytoma - fibrous - malignant | Subcutis |
0.4 |
0.3 |
References: Maita K, Toxicol Pathol 1988;16(3):340-9 |
||||
| (Unspecified organ) lesion | (Unspecified organ) | diethylstilbestrol (DES) |
0 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| (Unspecified organ) neoplasia | (Unspecified organ) | New western diet (NWD) TD.96096 ⋅ AIN-76A |
observed |
References: Poutahidis T, Cancer Res 2015 Apr 1;75(7):1197-204 |
||||
| (Unspecified organ) neoplasm | (Unspecified organ) |
0 - 86 |
0 - 83 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
||||
| (Unspecified organ) neoplasm | (Unspecified organ) | 3'-azido-3'-deoxythymidine (AZT) |
0 - 22.2 |
0 - 32.1 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| (Unspecified organ) neoplasm | (Unspecified organ) | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
0 |
0 - 8.7 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| (Unspecified organ) neoplasm | (Unspecified organ) | sodium barbital (BB) |
0 |
0 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| (Unspecified organ) neoplasm - benign | (Unspecified organ) |
37 - 38 |
55 - 56 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| (Unspecified organ) neoplasm - malignant | (Unspecified organ) |
41 - 49 |
24 - 28 |
References: Baldrick P, Toxicol Pathol 2007;35(4):562-9 |
||||
| (Unspecified organ) reticulum cell sarcoma | Neck |
14 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
|||||
| (Unspecified organ) reticulum cell sarcoma | Uterus | diethylstilbestrol (DES) |
8.3 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||
| (Unspecified organ) tumor | (Unspecified organ) | tamoxifen (TAM) |
0 |
References: Diwan BA, Carcinogenesis 1997 Oct;18(10):2009-14 |
||||
| (Unspecified organ) tumor | (Unspecified organ) |
0 - 53.5 |
0 - 54.5 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 ⋅ Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 ⋅ Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
||||
| (Unspecified organ) tumor | (Unspecified organ) | 3'-azido-3'-deoxythymidine (AZT) |
0 - 50 |
0 - 21.4 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| (Unspecified organ) tumor | (Unspecified organ) | sodium barbital (BB) ⋅ 3'-azido-3'-deoxythymidine (AZT) |
7.7 - 52.2 |
14.3 - 17.4 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| (Unspecified organ) tumor | (Unspecified organ) | sodium barbital (BB) |
16.7 - 45 |
0 - 4.5 |
References: Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
|||
| (Unspecified organ) tumor - benign | (Unspecified organ) |
29.4 |
38.1 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| (Unspecified organ) tumor - malignant | (Unspecified organ) |
24.1 |
16.4 |
References: Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 |
||||
| (Unspecified organ) tumor - mesenchymal | Back | diethylstilbestrol (DES) |
8.3 |
References: McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
||||